The Europe Opioids Market would witness market growth of 3.3% CAGR during the forecast period (2021-2027).
Chronic pain can be caused by a variety of factors. It could have started with an illness or an injury that a patient had already recovered from, yet the agony persisted. There could also be a long-term source of pain, such as arthritis or cancer. Many people experience chronic pain without ever having been injured or showing any signs of sickness.
Also, chronic pain has an impact on every aspect of the patient's life. Symptom alleviation and support are two of the most effective treatments. In order to give the necessary therapies to assist manage the pain, a multidisciplinary approach to pain management is frequently required. Outpatient pain management programs are the most common.
Depression (sometimes known as clinical depression or severe depressive disorder) is a common but significant mood illness. It creates severe symptoms that impact how individuals feel, think, and cope with daily tasks like sleeping, eating, and working. The symptoms of depression must be present for at least two weeks in order to be identified.
The United Kingdom's healthcare system, popularly known as the NHS, is a well-known and comprehensive system that is mostly sponsored by the government. It is considered to be one of the most effective and extensive healthcare systems in the world. The United Kingdom has the greatest level of spending in Europe, which is unsurprising. Furthermore, increased research efforts, increased pipeline medications, and the presence of multiple large businesses in the country present a huge opportunity for opioids in the country. The rise in the government investment in healthcare sector would also create more growth opportunities for the key market players.
German regulatory authorities' favourable payment policies in the areas of palliative care, non-abusive opioids, and opioid maintenance treatment (OMT) to treat opioid dependence (OD) have boosted potential in the opioids field.
The Germany market dominated the Europe Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $356.7 million by 2027. The UK market anticipated to grow at a CAGR of 2.5% during (2021 - 2027). Additionally, The France market would showcase a CAGR of 4% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Opioids Market Size will Hit $5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Opioids Market, by Application
1.4.2 Europe Opioids Market, by Product Type
1.4.3 Europe Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Opioids Market by Application
3.1 Europe Pain Management Market by Country
3.2 Europe Cough Treatment Market by Country
3.3 Europe Diarrhea Treatment Market by Country
Chapter 4. Europe Opioids Market by Product Type
4.1 Europe Methadone Market by Country
4.2 Europe Oxycodone Market by Country
4.3 Europe Hydrocodone Market by Country
4.4 Europe Fentanyl Market by Country
4.5 Europe Codeine Market by Country
4.6 Europe Morphine Market by Country
4.7 Europe Other Product Type Market by Country
Chapter 5. Europe Opioids Market by Country
5.1 Germany Opioids Market
5.1.1 Germany Opioids Market by Application
5.1.2 Germany Opioids Market by Product Type
5.2 UK Opioids Market
5.2.1 UK Opioids Market by Application
5.2.2 UK Opioids Market by Product Type
5.3 France Opioids Market
5.3.1 France Opioids Market by Application
5.3.2 France Opioids Market by Product Type
5.4 Russia Opioids Market
5.4.1 Russia Opioids Market by Application
5.4.2 Russia Opioids Market by Product Type
5.5 Spain Opioids Market
5.5.1 Spain Opioids Market by Application
5.5.2 Spain Opioids Market by Product Type
5.6 Italy Opioids Market
5.6.1 Italy Opioids Market by Application
5.6.2 Italy Opioids Market by Product Type
5.7 Rest of Europe Opioids Market
5.7.1 Rest of Europe Opioids Market by Application
5.7.2 Rest of Europe Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
TABLE 1 Europe Opioids Market, 2017 - 2020, USD Million
TABLE 2 Europe Opioids Market, 2021 - 2027, USD Million
TABLE 3 Europe Opioids Market by Application, 2017 - 2020, USD Million
TABLE 4 Europe Opioids Market by Application, 2021 - 2027, USD Million
TABLE 5 Europe Pain Management Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Pain Management Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Cough Treatment Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Cough Treatment Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 12 Europe Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 13 Europe Methadone Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Methadone Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Oxycodone Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Oxycodone Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Hydrocodone Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Hydrocodone Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Fentanyl Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Fentanyl Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Codeine Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Codeine Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Morphine Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Morphine Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Other Product Type Market by Country, 2021 - 2027, USD Million
TABLE 27 Europe Opioids Market by Country, 2017 - 2020, USD Million
TABLE 28 Europe Opioids Market by Country, 2021 - 2027, USD Million
TABLE 29 Germany Opioids Market, 2017 - 2020, USD Million
TABLE 30 Germany Opioids Market, 2021 - 2027, USD Million
TABLE 31 Germany Opioids Market by Application, 2017 - 2020, USD Million
TABLE 32 Germany Opioids Market by Application, 2021 - 2027, USD Million
TABLE 33 Germany Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 34 Germany Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 35 UK Opioids Market, 2017 - 2020, USD Million
TABLE 36 UK Opioids Market, 2021 - 2027, USD Million
TABLE 37 UK Opioids Market by Application, 2017 - 2020, USD Million
TABLE 38 UK Opioids Market by Application, 2021 - 2027, USD Million
TABLE 39 UK Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 40 UK Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 41 France Opioids Market, 2017 - 2020, USD Million
TABLE 42 France Opioids Market, 2021 - 2027, USD Million
TABLE 43 France Opioids Market by Application, 2017 - 2020, USD Million
TABLE 44 France Opioids Market by Application, 2021 - 2027, USD Million
TABLE 45 France Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 46 France Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 47 Russia Opioids Market, 2017 - 2020, USD Million
TABLE 48 Russia Opioids Market, 2021 - 2027, USD Million
TABLE 49 Russia Opioids Market by Application, 2017 - 2020, USD Million
TABLE 50 Russia Opioids Market by Application, 2021 - 2027, USD Million
TABLE 51 Russia Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 52 Russia Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 53 Spain Opioids Market, 2017 - 2020, USD Million
TABLE 54 Spain Opioids Market, 2021 - 2027, USD Million
TABLE 55 Spain Opioids Market by Application, 2017 - 2020, USD Million
TABLE 56 Spain Opioids Market by Application, 2021 - 2027, USD Million
TABLE 57 Spain Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 58 Spain Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 59 Italy Opioids Market, 2017 - 2020, USD Million
TABLE 60 Italy Opioids Market, 2021 - 2027, USD Million
TABLE 61 Italy Opioids Market by Application, 2017 - 2020, USD Million
TABLE 62 Italy Opioids Market by Application, 2021 - 2027, USD Million
TABLE 63 Italy Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 64 Italy Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 65 Rest of Europe Opioids Market, 2017 - 2020, USD Million
TABLE 66 Rest of Europe Opioids Market, 2021 - 2027, USD Million
TABLE 67 Rest of Europe Opioids Market by Application, 2017 - 2020, USD Million
TABLE 68 Rest of Europe Opioids Market by Application, 2021 - 2027, USD Million
TABLE 69 Rest of Europe Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 70 Rest of Europe Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 71 Key information –Johnson and Johnson
TABLE 72 Key Information – AstraZeneca PLC
TABLE 73 Key Information – Boehringer Ingelheim International GmbH
TABLE 74 key Information – Endo International PLC
TABLE 75 Key information – Mallinckrodt PLC
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 80 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.